Use of Ceftazidime-Avibactam and Ceftolozane-Tazobactam After Lung Transplantation

被引：0
|
作者：
Amore, Davide [1 ]
Pecoraro, Ylenia [1 ]
Carillo, Carolina [1 ]
Russo, Gianluca [4 ]
Poggi, Camilla [1 ]
Anile, Marco [1 ]
Pagini, Andreina [1 ]
Bassi, Massimiliano [1 ]
Cagnetti, Sara [1 ]
Mottola, Emilia [1 ]
D'Agostino, Federica Gilda [1 ]
Vannucci, Jacopo [1 ]
Mantovani, Sara [1 ]
Pugliese, Francesco [2 ]
De Giacomo, Tiziano [1 ]
Rendina, Erino Angelo [3 ]
Venuta, Federico [4 ]
Diso, Daniele [1 ]
机构：
[1] Sapienza Univ Rome, AOU Policlin Umberto I, Div Thorac Surg & Lung Transplant, Viale Policlin 155, I-00161 Rome, Italy
[2] Sapienza Univ Rome, AOU Policlin Umberto I, Div Anesthesiol & Intens Care, Unit Organs Transplant, Rome, Italy
[3] Sapienza Univ Rome, AOU St Andrea, Div Thorac Surg, Rome, Italy
[4] Sapienza Univ Rome, AOU Policlin Umberto I, Div Infect Dis, Rome, Italy
来源：
TRANSPLANTATION PROCEEDINGS | 2020年 / 52卷 / 05期
关键词：
CYSTIC-FIBROSIS; INFECTIONS; PNEUMONIA;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1605 / 1607
页数：3
相关论文
共 50 条
  • [41] Susceptibility of Meropenem-Resistant and/or Carbapenemase-Producing Clinical Isolates of Enterobacterales (Enterobacteriaceae) and Pseudomonas aeruginosa to Ceftazidime-Avibactam and Ceftolozane-Tazobactam as Assessed by In Vitro Testing Methods
    Cortazzo, Venere
    Posteraro, Brunella
    Menchinelli, Giulia
    Liotti, Flora Marzia
    D'Inzeo, Tiziana
    Fiori, Barbara
    Luzzaro, Francesco
    Sanguinetti, Maurizio
    Spanu, Teresa
    ANTIBIOTICS-BASEL, 2022, 11 (08):
  • [42] Molecular characterization of clinically isolated Pseudomonas aeruginosa with varying resistance to ceftazidime-avibactam and ceftolozane-tazobactam collected as a part of the ATLAS global surveillance program from 2020 to 2021
    Li, H.
    Oliver, A.
    Shields, R. K.
    Kamat, S.
    Stone, G.
    Estabrook, M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024,
  • [43] Evaluation of in-vitro susceptibility of β-lactam-resistant Gram-negative bacilli to ceftazidime-avibactam and ceftolozane-tazobactam from clinical samples of a general hospital in southern Brazil
    Carvalho, Thaisa Noceti
    Kobs, Vanessa Cristine
    Hille, Daniela
    Deglmann, Roseneide Campos
    Melo, Luiz Henrique
    Condeixa de Franca, Paulo Henrique
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2023, 56
  • [44] CEFTOLOZANE/TAZOBACTAM AND CEFTAZIDIME/AVIBACTAM AGAINST MEROPENEM-RESISTANT PSEUDOMONAS AERUGINOSA
    Grupper, Mordechai
    Sutherland, Christina
    Nicolau, David
    CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [45] Treatment of bone and joint infections by ceftazidime/avibactam and ceftolozane/tazobactam: a cohort study
    Rempenault, Claire
    Pagis, Valentine
    Noussair, Latifa
    Berbescu, Simona
    Duran, Clara
    Bouchand, Frederique
    de Laroche, Marine
    Salomon, Elsa
    Nich, Christophe
    Bauer, Thomas
    Rottman, Martin
    Davido, Benjamin
    Matt, Morgan
    Dinh, Aurelien
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 25 : 282 - 286
  • [46] Ceftolozane/tazobactam and ceftazidime/avibactam for the treatment of complicated intra-abdominal infections
    Goodlet, Kellie J.
    Nicolau, David P.
    Nailor, Michael D.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1811 - 1826
  • [47] MORTALITY AND LOS COMPARISON: CEFTAZIDIME/AVIBACTAM OR CEFTOLOZANE/TAZOBACTAM VS TRADITIONAL THERAPY
    Marrero, Efrain
    Delahanty, Ryan
    Alvarez, Joann
    CRITICAL CARE MEDICINE, 2019, 47
  • [48] What is the role of the new -lactam/-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?
    Gentile, Ivan
    Maraolo, Alberto Enrico
    Borgia, Guglielmo
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2016, 14 (10) : 875 - 878
  • [49] The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia
    Clerici, Daniela
    Oltolini, Chiara
    Greco, Raffaella
    Ripa, Marco
    Giglio, Fabio
    Mastaglio, Sara
    Lorentino, Francesca
    Pavesi, Francesca
    Farina, Francesca
    Liberatore, Carmine
    Castiglion, Barbara
    Din, Chiara Tassan
    Bernardi, Massimo
    Corti, Consuelo
    Peccatori, Jacopo
    Scarpellini, Paolo
    Ciceri, Fabio
    Castagna, Antonella
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (06)
  • [50] In vitro activities of cefiderocol (S-649266), ceftazidime-avibactam, ceftolozane-tazobactam, and other comparative drugs against Pseudomonas aeruginosa, Acinetobacter baumannii and Stenotrophomonas maltophilia associated with bloodstream infections
    Hsueh, Shun-Chung
    Huang, Yu-Tsung
    Liao, Chun-Hsing
    Lee, Yuarn-Jang
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S48 - S49
12345